Skip to main content
Equibles
SGMT logo

SGMT · Sagimet Biosciences Inc. · Metrics

Track SGMT — free

Use SGMT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SGMT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$10.42 +0.86 (+9.00%) At close · Oct 27
Russell 2000 member Rebalance outlook locked
Market Cap
$599.83M
Shares
62.16M
Volume · Oct 27 1.11M Avg daily vol (3M) 1.32M

SGMT metrics

63 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$10.42
Market cap
$599.83M

Price action

20 metrics
Price change (1W)
+7.9%
Price change (30D)
-3.8%
Price change (3M)
+28.3%
Price change (6M)
+17.7%
Price change (YTD)
+61.5%
Price change (1Y)
+4.6%
Trailing year
Price change (5Y)
—
52-week high
$11.17
52-week low
$4.55
Change from 52-week high
-14.4%
Change from 52-week low
+110.1%
Annualized volatility
81.9%
Annualized volatility (3M)
75.7%
Beta
1.9
RSI (14D)
52.4
Price vs SMA 50
-3.8%
Price vs SMA 200
+28.9%
Avg volume (3M)
1.31M
Relative volume
0.6
Average dollar volume
$12.52M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
62.16M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
2.3
reciprocal yield 43.2%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-7.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-05-12

Profitability

9 metrics
Gross margin
—
Operating margin
-1,537.0%
Trailing 12 months
Net margin
-1,393.8%
Gross profit (TTM)
—
Operating profit (TTM)
−$52.63M
Net income (TTM)
−$47.08M
Trailing 12 months
Diluted EPS (TTM)
$-1.29
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-1.43
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-1.28
Operating cash flow per diluted share (TTM)
$-1.15
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$0.94
Stock compensation per diluted share (TTM)
$0.23
Book value per share
$-1,010.08

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+65.0%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-18.4%
Return on assets
-17.9%
Debt / equity
0.0
Current ratio
45.0
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
45.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$240.13M
Latest balance sheet
Cash & equivalents
$165.90M
Total assets
$263.43M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$41.72M
Capital expenditures (TTM)
—
R&D (TTM)
$34.99M
SG&A (TTM)
—
Stock compensation (TTM)
$8.91M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
123
13F filer change QoQ
+35
Institutional ownership
83.2%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+235.9%
Holder tenure
4.7
Price vs estimated holder cost
+12.4%

Ownership (registered funds)

1 metrics
Index-fund ownership
11.5%

Short interest

3 metrics
Short interest
18.5%
Latest settlement · 8.2 days to cover
Days to cover
8.2d
Short-squeeze score
82 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$3.79M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1400118 CUSIP 786700104 13F (30d) 13 filings 13 filers Visit website Investor relations